PMC:7243778 / 10475-11152
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 225 | 488-496 | Species | denotes | SARS-CoV | Tax:694009 |
| 226 | 498-506 | Species | denotes | MERS-CoV | Tax:1335626 |
| 227 | 515-532 | Species | denotes | novel coronavirus | Tax:2697049 |
| 228 | 533-543 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 229 | 35-51 | Disease | denotes | viral infections | MESH:D001102 |
| 230 | 265-273 | Disease | denotes | infected | MESH:D007239 |
| 231 | 391-400 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T46 | 203-208 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T47 | 274-279 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T27 | 35-51 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T28 | 391-400 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T29 | 488-496 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T30 | 533-541 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T124 | 165-172 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T125 | 203-208 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T126 | 274-279 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T127 | 325-327 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T128 | 426-428 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T129 | 552-554 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T43 | 194-202 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T19 | 35-51 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
| T20 | 287-292 | http://purl.obolibrary.org/obo/GO_0019835 | denotes | lysis |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T81 | 0-130 | Sentence | denotes | Neutralizing Abs can fight against viral infections by blocking binding to cellular receptors or by interfering with viral fusion. |
| T82 | 131-320 | Sentence | denotes | Besides, in the case of enveloped viruses, the Abs can recruit effector cells or the complement, thus allowing the destruction of the infected cells or the lysis of the viral particles [6]. |
| T83 | 321-401 | Sentence | denotes | The S1 domain contains most of the epitopes recognized by nAbs during infection. |
| T84 | 402-569 | Sentence | denotes | The RBD located in this S1 domain would be the most important target for nAbs against SARS-CoV, MERS-CoV and the novel coronavirus SARS-CoV-2 [[26], [27], [28], [29]]. |
| T85 | 570-677 | Sentence | denotes | More specifically, certain secondary structures such as extended loops seem to be particularly immunogenic. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32450171-15163706-66454454 | 546-548 | 15163706 | denotes | 26 |
| 32450171-27936982-66454455 | 552-554 | 27936982 | denotes | 27 |